Potential diagnostic value of P16 expression in premalignant and malignant cervical lesions.

Narges Izadi‐Mood, Leila Hashemi Chelavi, Soheila Sarmadi, Seyed Ali Ahmadi, Kourosh Asadi, Hadi Shojaei(Cooper University Health Care), Sanaz Sani

PubMed

May 1, 2012

Cited by 36

Related Papers

MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress

|Molecular Cancer|2014|559

Pulse methotrexate versus pulse actinomycin D in the treatment of low‐risk gestational trophoblastic neoplasia

|International Journal of Gynecology & Obstetrics|2008|68

Efficacy of Megestrol Acetate (Megace) in the Treatment of Patients With Early Endometrial Adenocarcinoma: Our Experiences With 21 Patients

|International Journal of Gynecological Cancer|2009|65

Chronic Pain after Spinal Cord Injury: Results of a Long-Term Study

|Pain Medicine|2010|56

Comparison of pulsed actinomycin D versus 5‐day methotrexate for the treatment of low‐risk gestational trophoblastic disease

|International Journal of Gynecology & Obstetrics|2011|51